Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 1997

View Archived Issues

Epitope reacquires marketing rights from SmithKline Beecham for oral HIV diagnostic

Cell adhesion inhibitors disclosed by Hoechst

Novel immunomodulating agents from Gruenenthal

HMR discovers elastase inhibitors and prodrugs thereof

Agents for Parkinson's disease prepared at Rhone-Poulenc Rorer

New oral carbapenems with enhanced antibacterial activity

Antimicrobial DHFR inhibitors from Roche

Potential antitumor agents evaluated by Taiwan researchers

Osteoporosis test from Cortecs nearing launch

Antiobesity drug therapy

Clinical pharmacokinetics, safety and efficacy of orlistat

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

Caelyx approved in Australia and New Zealand

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

Troglitazone approved in the U.K.

Korean researchers describe new cephalosporins

AEterna reports promising safety profile for Neovastat

Japanese investigators present agents for restenosis

Topical antiinflammatory steroids devoid of glucocorticoid-like side effects

Potent calpain inhibitor discovered at Senju

Clinical trial of Lipitor for the reduction of cholesterol in women

U.S. Bioscience: Q2 1997 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...